Information Provided By:
Fly News Breaks for February 27, 2015
PODD
Feb 27, 2015 | 07:40 EDT
As noted earlier, Oppenheimer downgraded Insulet to Perform from Outperform. As reasons for the downgrade, the firm cited the company's lower than expected 2015 guidance and unfavorable product mix. Target to $33 from $39.
News For PODD From the Last 2 Days
PODD
PODD
PODD
May 10, 2024 | 07:34 EDT
Canaccord raised the firm's price target on Insulet to $234 from $226 and keeps a Buy rating on the shares. The firm said they are becoming more bullish given the significant T2 opportunity that they believe could provide a multi-year tailwind for the company.
PODD
May 9, 2024 | 18:44 EDT
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSSweetgreen (SG) up... To see the rest of the story go to thefly.com. See Story Here
PODD
PODD
May 9, 2024 | 13:06 EDT
Notable companies reporting after the market close, with earnings consensus, include Mettler-Toledo (MTD), consensus $7.64... Akamai Technologies (AKAM), consensus $1.61... Insulet (PODD), consensus 39c... Dropbox (DBX), consensus 50c... JFrog (FROG), consensus 14c... Synaptics (SYNA), consensus 49c... Array Technologies (ARRY), consensus (3c).
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.